Streetbeat News

Earnings

ARWR

Arrowhead Pharma (NASDAQ:ARWR) is expected to release its quarterly earnings report on Wednesday, 2023-11-29, with an estimated EPS of $-0.60. Investors are looking for a beat on this estimate and positive guidance for future growth. Historically, Arrowhead's stock price has been sensitive to earnings performance and guidance, with a 10.78% drop after missing EPS last quarter. Over the past year, ARWR shares have declined by 11.96%.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:01 pm

NCNO

Ncino (NASDAQ:NCNO) is expected to release its quarterly earnings report on Wednesday, 2023-11-29, with an estimated EPS of $0.11. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Ncino has had a mixed impact on its stock price post-earnings, with the last quarter resulting in a 9.74% increase after beating EPS estimates. Shares are currently trading at $30.21, up 15.66% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:01 pm

FL

Foot Locker (NYSE:FL) is expected to report Q3 2023 earnings with an estimated EPS of $0.25 on Wednesday, 2023-11-29. Investors are looking for an earnings beat and positive guidance for the next quarter. Last quarter, FL's EPS met estimates, resulting in a 4.93% stock price increase the following day. Historically, FL's stock price has reacted variably to earnings reports. Currently, FL shares are trading at $23.11, with a 52-week decrease of 41.93%, indicating bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:01 pm

NTNX

Nutanix (NASDAQ:NTNX) is expected to release its quarterly earnings report on Wednesday, 2023-11-29, with an estimated EPS of $0.17. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Nutanix has experienced significant stock price movements following their earnings reports. Last quarter, the company beat the EPS estimate by $0.08, resulting in a 12.22% stock price increase the next day. Over the last 52-week period, Nutanix shares have risen by 44.48%, with the stock currently trading at $40.83.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:00 pm

HRL

Hormel Foods (NYSE:HRL) is expected to release its quarterly earnings report on Wednesday, 2023-11-29, with analysts predicting an EPS of $0.45. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Hormel Foods's stock price has shown sensitivity to earnings performance and guidance. The stock is currently trading at $31.96, down 31.7% over the last 52 weeks, indicating potential concern among long-term shareholders ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:00 pm

FIVE

Five Below (NASDAQ:FIVE) is expected to report Q3 earnings with an EPS of $0.23 on November 29, 2023. Investors are looking for an earnings beat and positive guidance for the next quarter. Historical data shows mixed stock price reactions to past earnings reports. Shares are currently trading at $191.0, with an 18.65% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:00 pm

HNRA

HNR Acquisition Corp has announced that the results from its recent acquisition will only be included for the last six weeks of Q4 2023. This indicates that the acquisition was completed close to the end of the quarter, and its financial impact will be partially reflected in the quarter's results.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:55 pm

IWINF

Irwin Naturals Inc. reported a decrease in Q3 revenue to $19.1 million from $22.0 million YOY and a net loss of $1.96 million, up from $583,000 YOY. Despite falling revenue and surging losses, the company saw success in its cannabis sector licensing initiative and expanded its mental health footprint with the acquisition of Ketamine Media. The company also sold assets of underperforming clinics, focusing on wholly owned operations, and signed ten brand licensing deals for THC products in various regions.

Portfolio Pulse from Nina Zdinjak

November 28, 2023 | 1:50 pm

AMZN

CRWD

CrowdStrike (NASDAQ:CRWD) is expected to report strong quarterly earnings after the market close on Tuesday. The company's share price has seen significant growth, doubling over the year. CrowdStrike anticipates Q3 revenues between $775-$778 million, with Zacks Equity Research's consensus estimate at $777.2 million and expected EPS of 74 cents. Needham raised CrowdStrike's price target from $215 to $245, citing new products and a strong customer deal pipeline. However, Zacks noted potential negative impacts on the bottom line due to increased costs and investments, and does not predict a definitive earnings beat.

Portfolio Pulse from Neil Dennis

November 28, 2023 | 1:50 pm

BNS

Scotiabank's stock price has declined following the release of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:47 pm